Published: 2017-03-28

Inherited thrombophilia in young Indian adults presenting with thrombotic vascular events

Ravindranath Sahay, Priya Bhate, Nikhil A. Borikar


Background: There is limited Indian data available regarding inherited thrombophilias. This study was to determine the prevalence of inherited thrombophilias in young Indian patients presenting with thrombotic events.

Methods: This study was done at a tertiary hospital in Western India over a period of 20 months. Epidemiological, clinical and laboratory data was recorded of all consecutive patients aged 16 to 45 admitted with arterial and venous thrombotic vascular events. Blood samples for the thrombophilia profile were sent. Data was tabulated and analyzed using microsoft excel and graph pad software.

Results: 49 patients aged 15 to 45 years, admitted with thrombotic vascular events a period of 20 months were included. 26 (53.1%) were male. The mean age was 22.2±7 years. 20 (40.8%) patients; 10 (38.5%) males and 10 (43.5%) females had at least one thrombophilia. The commonest thrombophilia in both arterial and venous thrombotic events was hyperhomocysteinemia.

Conclusions: Young patients with thrombotic vascular events should be tested for thrombophilias since they are an important risk factor in this subset of patients.


Thrombophilia, Young

Full Text:



Hume M, Sevitt S, Thomas DP. Venous Thrombosis and pulmonary embolism. Harvard University Press; Cambridge, MA: 1970.

Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart and legs. The Framingham Study. J Am Med Ass. 1972;221:661.

Lowe GDO, Rumley A, Woodward M. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97:775-84.

Rumley A, Emberson JR, Wannamethee SG. Effects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost. 2006;4:982-7.

Seligsohn U, Lubetsky A. Genetic Susceptibility to Venous Thrombosis. N Engl J Med. 2001; 344:1222-31.

Konkle BA. Bleeding and Thrombosis. In: Kasper DL, Fauci AS, Longo DL, Hauser SL, Jameson JL, Loscalzo J eds. Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw-Hill; 2001:400-406.

Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: A study from Western India. Hepatology. 2001;34(4 Pt 1):666-70.

Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R. Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis. Am J Clin Pathol. 2004;121:844-847.

Sharma S, Kumar SI, Poddar U, Yachha SK, Aggarwal R. Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India. Indian J Gastroenterol. 2006;25(5):236-9.

Narayan D, Kaul S, Ravishankar K, Suryaprabha T, Bandaru VS, Mridula KR, et al. Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: Insights from Nizam's Institute Venous Stroke Registry, Hyderabad (India). Neurol India. 2012;60:154-9.

Liedeaard O, Soe M, Andersen MV. Cerebral thromboembolism among young women and men in Denmark 1977-1982. Stroke. 1986;206:337-44.

Lipska K, Sailaja PN, Sharma PS, Thankappan KR, Kutty VR, Vasan RS, et al. Risk factors for acute ischemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry. 2007;78;959-63.

De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost. 1994;72(3):352-8.